Where does Chia Tai Tianqing Pharmaceutical Group Co., Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Chia Tai Tianqing Pharmaceutical Group Co., Ltd. ranks #3,274 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Chia Tai Tianqing Pharmaceutical Group Co., Ltd. hold?

Chia Tai Tianqing Pharmaceutical Group Co., Ltd. holds 114 US utility patents granted between 2017 and 2025, spanning 15 technology areas.

What is Chia Tai Tianqing Pharmaceutical Group Co., Ltd.'s Innovation Score?

Chia Tai Tianqing Pharmaceutical Group Co., Ltd. has an Innovation Score of 44.6 out of 100 (top 25% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Chia Tai Tianqing Pharmaceutical Group Co., Ltd.'s patent grant rate increasing or decreasing?

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.'s recent grant velocity is +184% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Chia Tai Tianqing Pharmaceutical Group Co., Ltd.'s patents?

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.'s patents average 16.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Q: What technology areas does Chia Tai Tianqing Pharmaceutical Group Co., Ltd. focus on?

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.'s top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 100 patents, ranking #154 of 6,058 assignees active in that subclass. Grants appear in 15 CPC subclasses total.

Q: How is the Chia Tai Tianqing Pharmaceutical Group Co., Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 114 granted patents across 15 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Chia ranks #3,274 of 49,997 tracked US assignees by granted-patent volume, with 114 patents across 15 technology areas.

#3,274
of 49,997 US assignees by volume: Top 25%
by Innovation Score (44.6/100): 16.8
avg claims per patent: +184%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R3274 · Foreign Corporation #3,274 · 114 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MID 114 grants
TOP-DECILE #3,274/49,997
PHOTO-FINISH Abbyy Development
CPC-FOCUS A61P · 15 areas
INNOV-PAR 44.6/100
CLAIMS-RICH 16.8 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +184% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Abbyy Development Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Chia’s 44.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 16.4 pts (37%) Velocity 4.5 pts (10%) Breadth 13.7 pts (31%) Claim depth 10.1 pts (23%)

Qualcomm Incorporated · highest

85
Avinger · near

45
Chia Tai Tianqing… · this assignee

45
Educational Testing… · near

45
Samsonite IP… · near

45
Telia AB · near

45
3D Lighting… · lowest

7

What this shows Chia's Innovation Score is 44.6/100 (top 25% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Chia?

Each dot is one of Chia’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Chia’s own 16.8 claims/patent is at or below the 17.7 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Chia vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Chia's grants concentrate

Chia Tai Tianqing Pharmaceutical Group Co., Ltd. is a focused PatentsView assignee: 15 CPC subclasses with 87.7% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2020 (24 grants) versus a trough of 4 in 2017. By volume, Chia sits between Abbyy Development Inc. and Exfo Inc..

Chia's three-year grant acceleration

From 2019–2021 to 2022–2024, Chia Tai Tianqing Pharmaceutical Group Co., Ltd. moved from 49 to 33 grants (0.67x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #2,238. See the growth leaderboard.

Abbyy Development

114
Asana

114
Baidu COM Times T…

114
Bard Peripheral V…

114
Creeled

114
Dreamwell

114
Equinor Energy AS

114
Exfo

114
Chia Tai Tianqing… ◀

114

What this shows Chia holds 114 patents at rank #3,274, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Chia

By rank, the assignees closest to #3,274 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Chia's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Chia, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Chia ranks #154 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (45 here).

Educational Testing Service 45 Samsonite IP Holdings S.a r.l. 45 Telia Company AB 45 Avinger, Inc. 45

Similar claim depth

Nearest assignees by average claims per patent (16.8 here).

Synaptive Medical Inc. 16.8 avg Ningbo Sunny Opotech Co., Ltd. 16.8 avg University OF Copenhagen 16.8 avg Clarius Mobile Health Corp. 16.8 avg

Chia's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

45 Top 25% higher than 75% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Chia Tai Tianqing Pharmaceutical Group Co., Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	4	3.5%
2018	10	8.8%
2019	11	9.6%
2020	24	21.1%
2021	14	12.3%
2022	14	12.3%
2023	7	6.1%
2024	12	10.5%
2025partial year	18	15.8%

Which technologies does Chia Tai Tianqing Pharmaceutical Group Co., Ltd. patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 100

C07D - Heterocyclic Compounds 85

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 71

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 29

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 8

C07K - Peptides 8

C07C - Acyclic OR Carbocyclic Compounds 7

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 7

C07J - Steroids 5

Y02A - Technologies FOR Adaptation TO Climate Change 3

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 2

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 1

B01D - Separation 1

C30B - Single-crystal Growth ; Unidirectional Solidification OF Eutectic Material OR Unidirectional Demixing OF Eutectoid MATERIAL; Refining BY Zone-melting OF Material ; Production OF A Homogeneous Polycrystalline Material With Defined Structure ; Single Crystals OR Homogeneous Polycrystalline Material WI 1

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 1

Top 15 of 15 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.'s patent record in context - here's where to go next.

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 87.7% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #3,274 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Chia Tai Tianqing Pharmaceutical Group Co., Ltd. against Abbyy Development Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 44.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.